The strategy of prevention: lessons from cardiovascular disease
G. Rose
Rose coins the term “the prevention paradox”
in this paper based on his Adolf Streicher
memorial lecture in 1980; defined as “a measure
that brings large benefits to the community
offers little to each participating individual.”...
Sick individuals and sick populations
G. Rose
In this classic paper, Rose reflects on the etiology
and prevention of disease as a clinician concerned
with sick individuals, and as an epidemiologist concerned
with sick populations...
An updated coronary risk profile. A statement
for health professionals
K. Anderson, P. W. Wilson, P. M. Odell, W. B. Kannel
The Framingham epidemiological study, which
started in 1948, followed up a cohort of healthy
white Americans who were free of cardiovascular
disease (CVD), and related their lifestyles,
physiology, and biochemistry to subsequent
development of CVD...
Management of raised blood pressure in New Zealand:
a discussion document
R. Jackson, P. Barham, J. Bills, T. Birch, L. McLennan, S. MacMahon, T. Maling
Jackson and colleagues’ seminal paper on the management
of raised blood pressure represented a
paradigm shift in thinking about the concept of
“hypertension” and its treatment. In the 1950s,
the first drugs for lowering blood pressure were
used to treat malignant hypertension, often symptomatic,
with very high blood pressure levels, and usually fatal if
left untreated...
Prevention of coronary heart disease in clinical practice.
Recommendations of the Task Force of the European Society
of Cardiology, European Atherosclerosis Society and European
Society of Hypertension
K. Pyörälä, G. De Backer, I. Graham, P. A. Poole-Wilson, D. Wood
In 1992, Kalevi Pyörälä, Professor of Medicine at the
University of Kuopio, brought together the European
Society of Cardiology, European Atherosclerosis
Society, and European Society of Hypertension in a
unique partnership to create a common European
agenda for prevention of coronary heart disease (CHD)...
Estimation of ten-year risk of fatal cardiovascular disease
in Europe: the SCORE project
R. M. Conroy, K. Pyörälä, A. P. Fitzgerald, S. Sans, A. Menotti, G. De Backer, D. De Backer,
P. Ducimetière, P. Jousilahti, U. Keil, et al; SCORE Project Group
The Joint European Societies’ recommendations
on coronary heart disease (CHD) prevention
in 1994 broke the mould of single risk factor
management by advocating total CHD risk
estimation as the prerequisite to deciding to
treat blood pressure or lipids...
Exercise-based rehabilitation for patients with coronary
heart disease: systematic review and meta-analysis of
randomized controlled trials
R. S. Taylor, A. Brown, S. Ebrahim, J. Jolliffe, H. Noorani, K. Rees, B. Skidmore, J. A. Stone,
D. R. Thompson, N. Oldridge
Evidence for cardiac rehabilitation was first summarized
by Oldridge who reported in 1988 that
patients receiving exercise therapy had fewer
cardiac deaths and longer survival compared
with those with usual medical care...
Meta-analysis: secondary prevention programs for patients
with coronary artery disease
A. M. Clark, L. Hartling, B. Vandermeer, F. A. McAlister
Clark et al, in this meta-analysis, aimed to determine
the effectiveness of secondary prevention
programs, with and without exercise, in
patients with coronary artery disease...
Multiple risk factor interventions for primary prevention
of coronary heart disease
S. Ebrahim, A. Beswick, M. Burke, G. Davey Smith
Evidence from single risk factor interventions such
as lowering blood pressure, or lowering cholesterol,
is impressive...
Prevention of cardiovascular disease. Guidelines
for assessment and management of cardiovascular risk
World Health Organization
Noncommunicable diseases, of which half
are due to cardiovascular disease (CVD), are
predicted to increase substantially over
the coming years, and much of this disease
burden will fall on low- and middle-income
countries...
|
